GABA B
receptors function as heterodimeric G-protein-coupled receptors for the neurotransmitter γ γ γ γ-aminobutyric acid (GABA). Receptor subtypes, based on isoforms of the ligand-binding subunit GABA B1 , are thought to involve a differential set of associated proteins. Here, we describe two mouse lines which allow a straightforward biochemical isolation of GABA B receptors. The transgenic mice express GABA B1 isoforms that contain sequences for a two-step affinity purification, in addition to their endogenous subunit repertoire. Comparative analyses of purified samples from the transgenic mice and wildtype control animals revealed two novel components of the GABA B1 complex. One of the identified proteins, potassium channel T1 domain-containing 12 (KCTD12), associates with heterodimeric GABA B receptors via the GABA B2 subunit. In transfected hippocampal neurons, KCTD12 augmented axonal surface targeting of GABA B2 . The mice equipped with tags on GABA B1 facilitate validation and identification of native binding partners of GABA B receptors, providing an insight into the molecular mechanisms of synaptic modulation.
receptors convey the metabotropic action of the main inhibitory neurotransmitter in the brain, γ-aminobutyric acid (GABA 1 )(1). They are concentrated at axonal boutons of GABAergic and glutamatergic neurons as well as in dendritic spines and shafts at extrasynaptic sites (2) . Presynaptic GABA B receptors primarily inhibit calcium channels regulating evoked neurotransmitter release, whereas postsynaptic GABA B receptors mainly open G-protein-regulated inwardly rectifying potassium channels (GIRKs) and thereby elicit slow inhibitory postsynaptic potentials. Additionally, GABA B receptor activation decreases the local cAMP level. GABA B receptors function as heteromeric G-proteincoupled receptors (GPCRs) consisting of two subunits, GABA B1 and GABA B2 . Heterodimerization is a prerequisite for both surface trafficking of the receptor and ligandstimulated activation of a G i/o -protein (3) .
Two N-terminal GABA B1 variants, termed GABA B1a and GABA B1b differing only by a pair of sushi repeats, that is exclusively present in GABA B1a , have been identified (4) . They originate from the use of alternative transcriptional start sites (3, 5, 6) and underlie functional subtypes of the GABA B receptor with differential localization to pre-and postsynaptic sites in hippocampus and cortex (7) (8) (9) . As the sushi repeats are the only difference between GABA B1a and GABA B1b , it is to be expected that proteins interacting with these domains target or retain the GABA B1a isoform to specific microdomains.
Consistently, a soluble recombinant protein of the two sushi repeats binds to neuronal membranes with low nanomolar affinity (10) . An interaction of one of the two sushi repeats with Fibulin-2 has been described (11) , but the functional implication remains elusive.
Further subtypes of the GABA B receptor may be formed by a compartment-specific interaction of additional proteins, e.g. effector channels, with the core GABA B receptor complex (12) . Furthermore, GABA B1 can associate with seven-transmembrane proteins different from GABA B2 and may thereby modulate the signal transduction of other receptor systems (13, 14) . Using the intracellular C-terminal domains of the GABA B receptor subunits as baits in genetic screens for interactors 2 like the yeast two-hybrid system, a number of proteins ranging from transcription factors and RNA-binding proteins over trafficking factors to cytoskeletal elements and scaffolding proteins were identified (3, 15, 16) . However, the native interactions of the GABA B receptor as an integral membrane protein complex may only be readily uncovered by biochemical isolation of the protein complex from brain membrane preparations followed by mass spectrometry analysis.
The direct approach, immunoprecipitation of solubilized GABA B receptor complexes relies on antisera that recognize the native conformation of GABA B1 or GABA B2 with high efficiency and specificity. As an alternative, tandem affinity purification (TAP) may be applied with the advantage of two consecutive purification steps under native conditions (17) . In S. cerevisiae the TAPstrategy allowed the generation of a large protein interaction map (18) . TAP proved useful in mammalian approaches as well (19) (20) (21) . The first TAP-based transgenic mouse proteomics approach targeted interactions of 14-3-3 proteins, very abundant cytoplasmic regulators of cell signalling, and revealed almost 40 novel 14-3-3ζ-binding proteins (22) . A TAP search for proteins binding to melatonin receptors stably expressed in HEK293 cells showed that this approach is also suitable to isolate GPCR complexes from a cellular environment (23) .
Here, we describe TAP of GABA B receptor complexes from mouse brain including genetic engineering of mice and analyses of purified fractions by immunoblotting and high accuracy mass spectrometry. The identification of two novel components of native GABA B receptors validated the approach.
EXPERIMENTAL PROCEDURES
DNA constructs -Constructs for heterologous expression of rat GABA B1a (GenBank accession number Y10369), HA-GABA B1a , HA-SBP-GABA B1a , rat GABA B2 (AF109405), HA-GABA B2 , HA-GABA B2 ∆921-940 and HA-GABA B2 ∆817-940, were generated using a CMV expression vector (24) . Constructs for the expression of GABA B1a -CBP-TEV-ProtA, rat GABA B1b (Y10370)-CBP-TEV-ProtA, mouse KCTD12 (NM_177715), and HA-GABA B2 (817-920) were generated in pcDNA3. The Nterminal tags, hemagglutinin (HA, amino acid sequence YPYDVPDYA) and HA-SBP (streptavidin-binding peptide, (25) ) directly follow the signal sequence or the start methionine, the C-terminal tags, CBP-TEVProtA (17) and HA, the last amino acids of the wild-type proteins. pEGFP-C2 was used for the generation of fusion proteins of EGFP with KCTD12, KCTD12-T1 (amino acids 1-134) and KCTD12-CT (amino acids 135-327).
Antibodies -Purchased primary antibodies used for western blotting: CASK (610782, BD Biosciences, 1:1000), GABA B1 (sc-14006, Santa Cruz Biotechnology, 1:1000; AB1531, Millipore, 1:2000), GFP (ab6556, Abcam, 1:5000), GRP78 (ab21685, Abcam, 1:200), NSF (612272, BD Biosciences, 1:5000), PSD-95 (MA1-046, ABR, 1:2000), HA (HA.11, Covance, 1:1000). The antibody to GABA B2 has been described previously (26) . Polyclonal antibody to KCTD12 was raised in rabbits against a synthetic peptide corresponding to amino acid residues 254-267 in mouse KCTD12 coupled to Limulus polyphemus hemocyanin (Biogenes, Germany). The antiserum was affinity purified using the immunogenic peptide.
Cell culture -Growth media and additives were purchased from Invitrogen. Cell lines were grown following standard protocols. Primary hippocampal neurons were prepared from newborn rats (postnatal day (P)0-P1) and plated on 12 mm glass coverslips coated with laminin and poly-L-lysine (Sigma-Aldrich) at a density of 10 5 cells per well in 24-well plates. BAC modification by ET cloningBacterial artificial chromosome (BAC) citb544e14 (AF532114), kindly provided by Kirsten Fischer Lindahl, was modified by homologous recombination in E. coli HS996 following previously described protocols (27) . A cassette consisting of the CBP-TEV-ProtA tag sequence and a kanamycin resistance gene was inserted into exon 18 of the GABA B1 gene (6) , directly 5′ to the stop codon (between nucleotides 146573 and 146574 of BAC citb544e14), using pBAD-ETγ (27) . Independently, a cassette encompassing the counterselection genes SacB (28) and RpsL (29) and a kanamycin resistance gene was inserted into GABA B1a exon 1a2 (6) , directly 3′ to the sequence encoding the signal peptide (between nucleotides 120273 and 120274 of BAC citb544e14) and replaced with an HA-SBP tagcoding sequence using pGETrec (30) , which was kindly provided by Panayiotis A. Ioannou. The integrity of recombinant clones was confirmed by southern blotting and DNA sequencing.
Generation of transgenic mouse linesTransgenic mice were generated essentially as described (31) . BACs were purified (Nucleobond AX500, Machery-Nagel), diluted at a concentration of approximatively 0.5 µg/µl (10 mM Tris pH 7.5, 0.5 mM EDTA, 30 nM spermine, 20 nM spermidine, 0.1 M NaCl) and microinjected into pronuclei resulting from F1-C57BL/6/CBA matings. The embryos were transferred to the oviduct of pseudopregnant F1-C57BL/6/CBA foster mothers. Progeny were genotyped by PCR analysis and founders, in which the modified BAC randomly inserted into the genome, mated onto a C57BL/6 background.
Aequorin assay -CHO/Gα 16 /mtAEQ cells (32), kindly provided by Atanas Ignatov, permanently expressing both mitochondriatargeted Apoaequorin and the G-protein alpha subunit Gα 16 , were plated into 96-well white/opaque microtiter plates (Nunc) and cotransfected with expression vectors for GABA B2 and wild-type or modified GABA B1a using Lipofectamine (Invitrogen). Two days later, the cells were loaded with coelenterazine (PerkinElmer) for 4 h and stimulated with (R)-Baclofen (Tocris) at concentrations ranging from 0.01 to 100 µM. The luminescent response was measured 15 s after stimulation using a microluminometer (MicroLumat Plus, PerkinElmer). The half maximal effective concentration (EC 50 ) values for Baclofenstimulated G-protein coupling were calculated by fitting the relative light units into a sigmoidal dose-response curve using Origin 7.0 (Microcal software).
In situ hybridization -In situ hybridization on frozen mouse brain sections was performed as described previously (33) . Briefly, brains were frozen on solid CO 2 and 16 µm sections were prepared on a cryostat (CM 3050-S, Leica microsystems) and collected onto microscope slides (SuperFrost Plus, Menzel). Sense and antisense [ 35 S]-dUTP labeled cRNA probes were generated by in vitro transcription (MAXIscript In Vitro transcription Kit, Ambion) of subcloned cDNA fragments. Probe sequences used: B1a, nucleotides 1-488 of rat GABA B1a (Y10369); B1a/b pan, nucleotides 560-1062 of rat GABA B1a . HA-SBP, sequence encoding HA-SBP; CBP-TEV-ProtA , nucleotides 36-555 of the sequence for the TAP tag (17) . The hybridized sections were exposed to Kodak Biomax MR film for 3 to 5 days, dipped in Kodak NTB-3 nuclear emulsion (both from GE Healthcare), exposed for 8 days to 3 weeks and counterstained with Mayer's hemalaun.
Electrophysiology -Acute transverse hippocampal slices (250 µm) were prepared from young (P21 -P31) transgenic and wild-type mice and recovered for one hour (first at 31°C for 30 min, then room temperature for at least 30 min) before starting whole-cell recordings at 31°C. Slices were submerged and perfused at 2 ml/min with artificial cerebrospinal fluid (ACSF, 125 mM NaCl, 25 mM NaHCO 3 , 2.5 mM KCl, 1.25 mM NaH 2 PO4, 1 mM MgCl 2 , 2 mM CaCl 2 , 25 mM Glucose; pH 7.4 with 95% O 2 /5% CO2). Excitatory or inhibitory postsynaptic currents (EPSCs or IPSCs) were electrically stimulated every 10 s by stimulating Schaffer collaterals in stratum radiatum about 150 µm from the pyramidal layer with a glass pipette filled with ACSF. Patch pipettes had resistances of 4-6 MΟhm when filled with internal solution (130 mM Cs-gluconate, 5.5 mM KCl, 10 mM HEPES, 1 mM EGTA, 4 mM MgATP, 0.5 mM Na 3 GTP, 10 mM Na-phosphocreatine, 5 mM QX-314; pH 7.25, 280-290 mOsm). The liquid junction potential (16.3 mV) was corrected. EPSCs or IPSCs were recorded with an EPC9 (HEKA) at the reversal potential for GABA (-80 mV) or AMPA (0 mV), respectively. Baclofen (50 µM) and CGP54626 (1 µM) were kept as aliquots (stocks of 10 mM and 5 mM), and solutions were freshly prepared on the day of the experiment. Holding currents were recorded in the presence of tetrodotoxin (TTX, 1 µM) with patch electrodes containing 125 mM K-gluconate, 10 mM Na-gluconate, 4 mM NaCl, 10 mM HEPES, 0.2 mM EGTA, 4 mM MgATP, 0.3 mM Na 3 GTP, 10 mM Na-phosphocreatine (pH 7.25, 280-290 mOsm). Recordings were excluded if input resistance and/or series resistance changed by more than 20%. Values are mean ± SEM, and statistical significance between the three genotypes was tested using one-way Anova.
Extraction of membrane proteins from mouse brains -All protein work was performed at 4°C if not stated otherwise. Whole brains were homogenized (Potter S, B. Braun Biotech) in sucrose buffer (320 mM sucrose, 1 mM NaHCO 3 , 1 mM MgCl 2 , 50 µM CaCl 2 and protease inhibitors [Complete, Roche Applied Science]) and nuclei removed (1,400 g, 10 min). Membranes were pelleted (20,000 g, 20 min), resuspended in solubilization buffer (400 mM NaCl, 10 mM Tris pH 8.0, 1% Triton X-100 and protease inhibitors) and incubated over night on a rotator. The membrane debris was removed by ultracentrifugation (100,000 g, 60 min). The resulting supernatant represents the solubilized membrane protein fraction.
Tandem affinity purification from NTAP-GABA B1a mice -40 to 70 mg of solubilized membrane proteins were prepared from juvenile (P10-P16) mouse brains and the 2-mercaptoethanol and EDTA concentrations were adjusted to 5 mM and 2 mM, respectively. The extract was rotated over night with 720 µl of streptavidin-coated magnetic beads (Dynabeads MyOne Streptavidin T1, Invitrogen). Afterwards, the beads were collected using a magnetic device (Invitrogen), washed three times with 1 ml solubilization buffer and bound material eluted with 2 mM biotin in 1600 µl solubilization buffer for 20 min on a rotating wheel. The biotin eluate was incubated with 160 µl of anti-HA affinity matrix (Roche) rotating for 4 h. After washing the beads three times with 1 ml solubilization buffer, the bound material was eluted in SDS-loading buffer (50 mM Tris-Cl pH 8.0, 200 mM DTT, 6% (w/v) SDS, 10% glycerol, 7 M urea, 0.01% (w/v) bromphenol blue) for 10 min at 42°C, separated on NuPage Novex gels (Invitrogen) and stained with silver nitrate as previously described (34) .
Tandem affinity purification from GABA B1a/b -CTAP mice -The purification was basically performed as previously described (17) . 40 to 70 mg of solubilized membrane proteins prepared from juvenile (P10-P16) mouse brains were incubated with 100 µl of IgG sepharose beads (GE Healthcare) rotating over night. The beads were collected by centrifugation (1 min, 1,000 g), washed three times with 1 ml solubilization buffer and resuspended in 300 µl of the same buffer. Bound material was eluted from the IgG matrix using 80 units of tobacco etch virus (TEV) protease (Invitrogen) shaking for 2 h at 16°C. The supernatant was collected, mixed with 900 µl calmodulin binding buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris-Cl pH 7.5, 7.5 mM β-mercaptoethanol, 0.75 mM MgAc, 0.75 mM imidazole, 2 mM CaCl 2 ) and the CaCl 2 concentration of the suspension adjusted to 2 mM. The suspension was incubated with 50 µl of calmodulin-agarose (Stratagene) rotating for 2 h. After washing the beads three times with 1 ml calmodulin binding buffer, the bound material was eluted in SDS-loading buffer and analyzed as described above.
Mass spectrometry analysis -The applied work-flow followed an established protocol (35) . Briefly, the protein bands were cut out of the gel and subjected to in-gel reduction of protein disulfide bonds using DTT and subsequent alkylation by addition of iodoacetamide. Next, the protein content was digested with trypsin over night at 37°C and the peptides were extracted from the gel and then concentrated and desalted by stop and go extraction (36, 37) . The samples were analyzed by LC-MS/MS using an Agilent 1200 HPLC system connected online to an LTQ-Orbitrap XL (Thermo Fisher Scientific). Fragment spectra were recorded in the LTQ and high resolution and mass accuracy spectra on the intact peptides in the Orbitrap (38) . Centroided peak lists were searched with Mascot v2.2 (Matrix Science) against the mouse IPI database (39) .
Coimmunoprecipitation -Solubilized membrane proteins (6 to 18 mg) of juvenile wildtype C57BL/6 mouse brains were supplemented with 10 µg monoclonal mouse anti-GABA B1 antibody (ab55051, Abcam) or mouse IgG as a control (Sigma) and rotated over night. The immune complexes were collected for 4 h on 50 µl Protein A beads (GE Healthcare), washed three times with 0.5 ml solubilization buffer and eluted in SDS-loading buffer.
Purification of HA-tagged proteins from transfected HEK293 cells -Two days after transfection with calcium phosphate the cells were washed, harvested, resuspended in 600 µl solubilization buffer and rotated over night. The extract was centrifuged for 1 h at 100,000 g and the supernatant incubated with 20 µl anti-HA affinity matrix (Roche) rotating for 4 h. The matrix was washed three times with 0.5 ml solubilization buffer and the bound protein eluted in SDS-loading buffer.
Immunofluorescence of cultured neurons -Dissociated rat hippocampal neurons were transfected using calcium phosphate at DIV7. Two days later, the neurons were incubated with mouse anti-HA antibody (HA.11, Covance, 1:500) in the growth medium for 30 min at 10°C. The neurons were washed with DMEM (Dulbecco's Modified Eagle Medium, Invitrogen), fixed with 4% (w/v) PFA/4% (w/v) Sucrose/PBS for 10 min, permeabilized with 0.25% Triton X-100/PBS for 10 min and blocked with 1% (w/v) BSA/PBS for 30 min, and rabbit anti-mictrotubule-associated protein 2 (MAP2) antibody (Synaptic Systems, 1:1000) was applied in 1% (w/v) BSA/PBS for 1 h. The fixation and all subsequent steps were performed at room temperature. After three brief washes with 1% (w/v) BSA/PBS, species-specific secondary antibodies (donkey anti-mouse Alexa546, Molecular Probes, 1:1000; donkey anti-rabbit Cy5, Jackson ImmunoResearch, 1:500) were applied in 1% (w/v) BSA/PBS for 1 h. 
RESULTS
An N-terminal and a C-terminal tandem affinity tag on GABA B1 -We set out to generate transgenic mice equipped with affinity tags for the purification of GABA B receptors. To this end, DNA sequences encoding two different TAP tags were independently inserted into BAC citb544e14 (40) , which contains a fragment of mouse chromosome 17 including the gene for GABA B1 , by homologous recombination in E. coli (27, 41) (Fig. 1A) . The classical TAP tag consisting of calmodulin-binding peptide (CBP), TEV protease recognition site and Protein A was appended to the C-terminus of GABA B1 (GABA B1 -CBP-TEV-ProtA). Alternatively, we added a tandem tag consisting of an HA epitope and a streptavidin-binding peptide (SBP) to the N-terminus of the mature GABA B1a polypeptide (HA-SBP-GABA B1a ). The purpose of the former construct was to allow purification of GABA B1 complexes irrespective of the isoform, whereas the latter should help isolating specifically GABA B1a -containing receptors (Fig. 1B) .
To check for the functional integrity of receptors containing these tags we employed an aequorin assay. GABA B1a carrying the two different tandem affinity tags either at the N-or C-terminus was coexpressed with GABA B2 in CHO/Gα 16 Fig.  2A) . However, in GABA B1a/b -CTAP mice the transgenic expression appeared slightly more pronounced in cortex and thalamus. Importantly, the BAC-derived messages recapitulated the celltype specific expression of GABA B1 isoforms in the cerebellum known from wild-type mice (42,43). Furthermore, expression of the TAPtagged GABA B1 proteins was readily detectable on western blots of brain membranes from the transgenic mice (Figs. 2B and 4A) .
To confirm that the genetic manipulation did not interfere with physiological GABA B receptor functions, we assessed baclofen effects in acute hippocampal slices of NTAP-GABA B1a , GABA B1a/b -CTAP and wild-type mice (Fig. 3) . Baclofen via activation of presynaptic GABA B receptors strongly reduced excitatory and inhibitory postsynaptic currents (EPSCs and IPSCs) recorded in CA1 pyramidal cells in all genotypes to similar extents (Fig. 3, A and B) . Comparable increases in holding currents by baclofen in all three genotypes indicated normal postsynaptic GABA B receptor function (Fig. 3C) .
Tandem affinity purification of GABA B1 -Membrane proteins were solubilized from brains of transgenic and wild-type mice and subjected to the respective TAP protocol. Western blot analysis of the final fractions (Fig. 4, A and B) revealed transgene-specific isolation not only of the tagged proteins, but also of GABA B2 , indicating that the integrity of the receptors was conserved throughout the purification. Two prominent synaptic proteins not implicated with GABA B receptors, CASK and PSD-95, were not detectable in the final fractions.
Silver staining of final TAP fractions separated by SDS-PAGE revealed complex patterns, but allowed identification of bands obviously enriched in the transgenic samples by visual inspection (Fig. 5) . These bands and their wild-type counterparts were isolated and subjected to trypsin digestion followed by LC-MS/MS. The peptide analysis revealed, besides GABA B receptor subunits, glucose-regulated protein 78 (GRP78/BiP) (44) in samples from NTAP-GABA B1a and potassium channel tetramerization domain containing 12 (KCTD12/pfetin) (45) in samples from GABA B1a/b -CTAP mice (Table 1) .
Western blots of the final TAP fractions confirmed the mass spectrometric identification of the two candidate GABA B receptor interactors (Fig. 6, A and B) . Moreover, anti-GABA B1 immunoprecipitates from wild-type mice contained both GRP78 and KCTD12 corroborating them as constituents of native GABA B1 receptor complexes (Fig. 6C) .
The T1 domain of KCTD12 interacts with GABA B receptors via the C-terminus of GABA B2 -The interaction between KCTD12 and the GABA B receptor was further assessed in transfected HEK293 cells (Fig. 7) . KCTD12 bound to GABA B2 , and not to GABA B1 , and allowed formation of a ternary complex consisting of GABA B1 , GABA B2 and KCTD12. We mapped the KCTD12 interaction site in GABA B2 to a region of the C-terminus distal to the membrane (amino acids 817-920). GABA B2 -binding was mediated by an N-terminal fragment of KCTD12 encompassing a voltage-gated potassium channel tetramerization (T1) domain (45) . Thus, KCTD12 appears to interact with functional GABA B receptors by T1-domainbinding to the C-terminal region of GABA B2 .
Influence of KCTD12 on the neuronal distribution of GABA B receptors -Transfection of KCTD12 constructs into primary neurons from rat hippocampus altered the distribution of coexpressed HA-GABA B2 (Fig. 8) . KCTD12 increased the amount of HA-GABA B2 at the surface of neurites. This effect was largely confined to regions which were negative for the dendritic marker MAP2. These data suggest that KCTD12 supports GABA B2 surface expression primarily in axonal domains. Thus, KCTD12 may have an impact on the axonal transport or suface stability of GABA B receptors.
DISCUSSION
Here we used tandem affinity purification from mouse brain to identify proteins associated with the GABA B receptor subunit GABA B1 . As expected from a BAC approach, mRNAs for the tagged receptor subunits were distributed similarly to their endogenous counterparts and the proteins were not strongly overexpressed by the genetic manipulation. In addition, the physiological preand postsynaptic effects of GABA B receptors were preserved. Thus, GABA B1 complexes isolated from these mice have a high chance to mimic the in vivo situation. The mice should therefore offer a convenient way to unravel native GABA B1 complexes. However, visual inspection of silver-stained gels loaded with purified fractions from transgenic and wild-type mice yielded a small number of complex-specific protein bands. This limitation is attributed to unspecific binding to the affinity matrices under the described conditions, which probably reflects the tagged target protein GABA B1 being only a minute constituent within the solubilized brain membranes used as source. The highest expression of GABA B1a occurs during the first postnatal days (3). We therefore tried purification from newborn NTAP-GABA B1a mice, but observed a pattern of silver-stained protein bands virtually identical to the one from P10-P16 mice.
The HA-SBP tag combination introduced here may offer advantages as compared to the established CBP-TEV-ProtA tag. The HA-SBP tag is rather small (56 amino acids; ~6 kDa) and might therefore show less interference with the trafficking and function of tagged target molecules. Moreover, substitution of the CBP tag may be preferred for purification from tissues with significant expression of calmodulin. However, we noted an unexpected loss of GABA B2 specifically during purifications from NTAP-GABA B1a mice (Fig. 4B) . It is possible that the HA tag is better accessible in unassembled HA-SBP-GABA B1a than in the heterodimer. The fact that we did not find KCTD12 in the NTAP-GABA B1a samples may result from the loss of GABA B2 .
Our data show that the chaperone protein GRP78 is binding to GABA B1 in vivo. Purified samples from NTAP-GABA B1a mice routinely showed a conspicuously strong band migrating slightly slower than a 75 kDa marker protein, which was identified as GRP78 by mass spectrometry. GRP78 is a luminal ER protein mainly involved with chaperone functions and the unfolded protein response (44, 46, 47) . However, a control western blot suggested that the transgenic receptor subunits did not lead to an obvious induction of GRP78, which would have been expected in case of an ER stress response (Fig. 6A) . In addition, we detected GRP78 not only in purified fractions from both transgenic mouse lines, but also in GABA B1 complexes immunoprecipitated from wild-type mice. GRP78-binding may mediate the maturation of the GABA B receptor, possibly by supporting the proper folding of the GABA B1 subunit and avoiding its aggregation until the heterodimer is formed. The particularly large amount of GRP78 found in the final fractions of the NTAP-GABA B1a mice may reflect that our purification scheme favoured isolation of the unassembled subunit (see above). The detection of a luminal ER protein as a binding partner by guest on September 16, 2017 http://www.jbc.org/ Downloaded from shows that the strategy used here is not limited to the isolation of cytoplasmic components and may therefore ultimately also allow identification of extracellular interactions of GABA B receptors.
Our analysis of GABA B1a/b -CTAP mice revealed KCTD12 as a novel complex constituent. However, few peptides for GABA B1 , GABA B2 and KCTD12 were also detected in the samples from wild-type mice, although in small numbers and lower intensities. As final fractions of GABA B1a/b -CTAP purifications from wildtype mice did not show bands in western blots with antibodies to GABA B1 , GABA B2 or KCTD12, we ascribe these peptides to contaminations that possibly occurred during isolation of the corresponding bands or the subsequent peptide separation. KCTD12 has been identified as a gene with predominant fetal expression, most prominently in cochlea and brain (45) . KCTD12/pfetin protein was reported to be a prognostic marker for gastrointestinal stromal tumors showing an inverse relation to tumor metastasis (48) . The KCTD12 protein contains a T1 domain (45) , that belongs to the family of BTB/POZ protein-protein interaction motifs with various cellular functions (49) . The T1 domain tetramer of voltage-gated potassium channels subserves β-subunit association controlling both channel properties and axonal/dendritic targeting (50) (51) (52) (53) (54) (55) . Interestingly, KCTD12 peptides have also been identified in synaptosomal preparations from mouse brain (56) , supporting a role of KCTD12 in synaptic transmission.
With the C-terminal region of GABA B2 we report the first binding site for the T1 domain in KCTD12. Importantly, this domain interaction allows association of KCTD12 with the heteromeric, functional GABA B receptor. Our experiments in transfected dissociated neurons suggest that KCTD12-binding may play a role in transport of the GABA B receptor to axonal plasma membrane sites reminiscent of the T1 domain in Kv channels (52, 54) , implying T1 domain interactions mediate subcellular targeting of selected neuronal membrane proteins. Given that GABA B receptors subserve various different functions in dendritic shafts, dendritic spines and axonal boutons in neurons of the brain, their precise localization is of pivotal importance. In summary, our data introduce the T1 domain protein KCTD12 as an integral part of GABA B receptors. The TAP-tagged mice may help to unravel the native protein composition of GABA B1 complexes in brain and other tissues. We are grateful to Julia Kuhlmann, Stefanie Wilhelm, Janina Sülflow and Andrea Zaisser for excellent technical assistance. We thank Irm Hermans-Borgmeyer for oocyte injections; Susanne Fehr for in situ hybridization; Chudamani Rasa Raithore for cultured neurons; and Michaela Schweizer for help with microscopy. This work was funded in part by the Deutsche Forschungsgemeinschaft (SFB444). 1 The abbreviations used are: ACSF, artificial cerebrospinal fluid; BAC, bacterial artificial chromosome; CBP, calmodulin-binding peptide; EC 50 , half maximal effective concentration; EPSCs, excitatory postsynaptic currents; GABA, γ-aminobutyric acid; GIRK, G-protein-regulated inwardly rectifying potassium channel; GPCR, G-protein-coupled receptor; GRP78, glucose-regulated protein 78; HA, hemagglutinin; IPSCs, inhibitory postsynaptic currents; KCTD12, potassium channel tetramerization domain containing 12; MAP2, microtubule-associated protein 2; P, postnatal day; SBP, streptavidin-binding peptide; T1 domain, voltage-gated potassium channel tetramerization domain; TAP, tandem affinity purification; TEV, tobacco etch virus; TTX, tetrodotoxin. FIGURE LEGENDS FIGURE 1. Targeting TAP sequences into the GABA B1 gene on BAC citb544e14. A, sequences coding for the HA-SBP tag were introduced into the GABA B1a -specific exon 1a2 (6), 3′ to the signal sequence, whereas sequences coding for the CBP-TEV-ProtA tag and a kanamycin resistance gene were inserted into exon 18 (6), 5′ to the stop codon. GABA B1a -specific exons are shown in light gray, the GABA B1b -specific region of exon 1a/b in dark gray. B, scheme of tagged and untagged GABA B1 isoforms in the BAC transgenic mice. TMD, transmembrane domain; sushi, sushi repeat. A 50% excess of wild-type material was loaded to facilitate the identification of protein bands specifically enriched in the transgenic fractions. These bands, which are marked by arrows, and the corresponding regions from the wild-type control lanes were analyzed using mass spectrometry (Table 1 ). (Fig. 4) were analyzed by LC-MS/MS. All unambiguously identified peptide sequences from the corresponding proteins are listed along with the score of the identification reported from the Mascot search engine and the deviation of the experimentally determined mass from the theoretical in parts per million. Asterisk indicates peptides also identified in wild-type control samples.
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